(Q43625604)

25 November 2017

Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma (English)

1 reference

25 November 2017

3

Hitoshi Tsuda

1 reference

25 November 2017

8

Kenji Tamura

1 reference

25 November 2017

10

Yae Kanai

1 reference

25 November 2017

9

Kazuaki Shimada

1 reference

25 November 2017

Shunsuke Kondo

1

1 reference

25 November 2017

Hidenori Ojima

2

1 reference

25 November 2017

Jun Hashimoto

4

1 reference

25 November 2017

Chigusa Morizane

5

1 reference

25 November 2017

Masafumi Ikeda

6

1 reference

25 November 2017

Hideki Ueno

7

1 reference

25 November 2017

Takuji Okusaka

11

1 reference

25 November 2017

5 January 2012

1 reference

International Journal of Clinical Oncology

25 November 2017

1 reference

25 November 2017

18

1 reference

25 November 2017

2

1 reference

25 November 2017

207-213

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-011-0361-9

25 November 2017

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Met receptor tyrosine kinase: enhanced signaling through adapter proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Met, metastasis, motility and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Drug development of MET inhibitors: targeting oncogene addiction and expedience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0361-9

c-met mRNA overexpression in human hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas

1 reference

12 December 2020

Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas

1 reference

12 December 2020

Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer

1 reference

12 December 2020

The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas

1 reference

12 December 2020

Targeting the c-MET signaling pathway for cancer therapy

1 reference

12 December 2020

Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma

1 reference

12 December 2020

Molecular prediction of early recurrence after resection of hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S10147-011-0361-9

Identifiers

DOI

1 reference

Dimensions Publication ID

25 November 2017

0 references

1 reference